Suppr超能文献

固体脂质颗粒作为药物载体——颗粒制备方法和脂质辅料对颗粒特性的影响。

Solid lipid Particles as Drug Carriers - Effects of Particle Preparation Methods and Lipid Excipients on Particle Characteristics.

作者信息

Gamboa Cintia Kieffer, Samir Ranoda, Wu Chengyu, Mu Huiling

机构信息

Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

出版信息

Pharm Nanotechnol. 2018;6(2):124-132. doi: 10.2174/2211738506666180420165547.

Abstract

BACKGROUND

Oral delivery of biopharmaceuticals is limited by the absorption barriers in the Gastrointestinal Tract (GIT) such as low permeability across the biological membranes and the enzymatic degradation by proteases. In this study, lipid-based drug delivery systems were proposed to overcome these obstacles.

OBJECTIVE

The aim of this study was to evaluate the effect of particle preparation methods and excipients on the characteristics of Solid Lipid Microparticles (SLM) and Solid Lipid Nanoparticles (SLN).

METHOD

Different triglycerides (TG) were used as the major excipients for the SLM and SLN. Insulin was used as the model protein; insulin-phospholipid (PL) was prepared to increase drug lipophilicity and compatibility with lipid excipients. Four methods were used for preparing lipid particles, i.e. a Hot Melting Dispersion (HMD) technique, a Solvent Evaporation (SE) method, a modified Solvent Evaporation (mSE) method and a Spray Drying technique. The lipid particles were evaluated in terms of size, size distribution, surface morphology and drug Entrapment Efficiency (EE).

RESULTS

The results suggested that SE method was the most suitable method for preparing insulin-PL loaded Solid Lipid Particles (SLP). No differences were observed when the SLP with a Long Chain Triglyceride (LCT) either a Medium Chain Triglyceride (MCT) in term of size. 70-90% of the lipidified insulin was incorporated in the lipid particles.

CONCLUSION

The preparation methods affected the size and morphology of SLP significantly, and the selection of lipid excipient should be done based on specific application requirements. Furthermore, the use of the lipidified protein was an efficient way to encapsulate protein in lipid carriers.

摘要

背景

生物制药的口服给药受到胃肠道(GIT)吸收屏障的限制,如生物膜的低渗透性以及蛋白酶的酶解作用。在本研究中,提出了基于脂质的药物递送系统来克服这些障碍。

目的

本研究的目的是评估颗粒制备方法和辅料对固体脂质微粒(SLM)和固体脂质纳米粒(SLN)特性的影响。

方法

不同的甘油三酯(TG)用作SLM和SLN的主要辅料。胰岛素用作模型蛋白;制备胰岛素 - 磷脂(PL)以增加药物的亲脂性以及与脂质辅料的相容性。使用四种方法制备脂质颗粒,即热熔分散(HMD)技术、溶剂蒸发(SE)法、改良溶剂蒸发(mSE)法和喷雾干燥技术。从粒径、粒径分布、表面形态和药物包封率(EE)方面对脂质颗粒进行评估。

结果

结果表明,SE法是制备载胰岛素 - PL固体脂质颗粒(SLP)最合适的方法。当SLP中使用长链甘油三酯(LCT)或中链甘油三酯(MCT)时,在粒径方面未观察到差异。70 - 90%的脂质化胰岛素被包封在脂质颗粒中。

结论

制备方法对SLP的粒径和形态有显著影响,应根据具体应用要求选择脂质辅料。此外,使用脂质化蛋白是将蛋白包封在脂质载体中的有效方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验